Next Article in Journal
Potential Use of Quercus dalechampii Ten. and Q. frainetto Ten. Barks Extracts as Antimicrobial, Enzyme Inhibitory, Antioxidant and Cytotoxic Agents
Previous Article in Journal
Essential Oils from Côa Valley Lamiaceae Species: Cytotoxicity and Antiproliferative Effect on Glioblastoma Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 15
Issue 2
10.3390/pharmaceutics15020342
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Pharmaceutics 2022, 14(7), 1511.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511

by
Yue-Zhi Lee
1,†,
Hsing-Yu Hsu
1,†,
Cheng-Wei Yang
1,†,
Yi-Ling Lin
2,
Sui-Yuan Chang
3,
Ruey-Bing Yang
2,
Jian-Jong Liang
2,
Tai-Ling Chao
3,
Chun-Che Liao
2,
Han-Chieh Kao
3,
Jang-Yang Chang
1,
Huey-Kang Sytwu
4,
Chiung-Tong Chen
1 and
Shiow-Ju Lee
1,*
1
Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan
2
Institute of Biomedical Sciences, Academia Sinica, Taipei 115021, Taiwan
3
Institute of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei 10617, Taiwan
4
National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli 35053, Taiwan
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Pharmaceutics 2023, 15(2), 342; https://doi.org/10.3390/pharmaceutics15020342
Submission received: 13 December 2022 / Accepted: 11 January 2023 / Published: 19 January 2023
Versions Notes
Changes to “authors who contributed equally”
In the original publication [1], the authors who had “contributed equally” were not listed. The corrected statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Lee, Y.-Z.; Hsu, H.-Y.; Yang, C.-W.; Lin, Y.-L.; Chang, S.-Y.; Yang, R.-B.; Liang, J.-J.; Chao, T.-L.; Liao, C.-C.; Kao, H.-C.; et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lee, Y.-Z.; Hsu, H.-Y.; Yang, C.-W.; Lin, Y.-L.; Chang, S.-Y.; Yang, R.-B.; Liang, J.-J.; Chao, T.-L.; Liao, C.-C.; Kao, H.-C.; et al. Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511. Pharmaceutics 2023, 15, 342. https://doi.org/10.3390/pharmaceutics15020342

AMA Style

Lee Y-Z, Hsu H-Y, Yang C-W, Lin Y-L, Chang S-Y, Yang R-B, Liang J-J, Chao T-L, Liao C-C, Kao H-C, et al. Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511. Pharmaceutics. 2023; 15(2):342. https://doi.org/10.3390/pharmaceutics15020342

Chicago/Turabian Style

Lee, Yue-Zhi, Hsing-Yu Hsu, Cheng-Wei Yang, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, Jian-Jong Liang, Tai-Ling Chao, Chun-Che Liao, Han-Chieh Kao, and et al. 2023. "Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511" Pharmaceutics 15, no. 2: 342. https://doi.org/10.3390/pharmaceutics15020342

APA Style

Lee, Y. -Z., Hsu, H. -Y., Yang, C. -W., Lin, Y. -L., Chang, S. -Y., Yang, R. -B., Liang, J. -J., Chao, T. -L., Liao, C. -C., Kao, H. -C., Chang, J. -Y., Sytwu, H. -K., Chen, C. -T., & Lee, S. -J. (2023). Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511. Pharmaceutics, 15(2), 342. https://doi.org/10.3390/pharmaceutics15020342

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop